Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial.
Drug Alcohol Depend Rep
; 52022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36644226
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article